Comparing Inflammatory Markers in Severe Infections
Author Information
Author(s): Gaïni Shahin, Koldkjær Ole G, Møller Holger J, Pedersen Court, Pedersen Svend S
Primary Institution: Odense University Hospital
Hypothesis
The study aims to investigate levels of HMGB1, LBP, and PCT in a well-characterized sepsis cohort.
Conclusion
Levels of HMGB1, PCT, and LBP were higher in infected patients compared to healthy controls, and higher in severe sepsis patients compared to those with sepsis.
Supporting Evidence
- HMGB1, LBP, and PCT levels were significantly higher in infected patients compared to healthy controls.
- PCT had the best performance in distinguishing between bacteraemic and nonbacteraemic patients.
- None of the inflammatory markers had prognostic abilities in identifying patients with fatal outcomes.
Takeaway
Doctors looked at three proteins in sick patients to see if they could help tell how bad their infections were. They found that higher levels of these proteins meant more serious infections.
Methodology
Patients suspected of severe infections were included, and levels of inflammatory markers were measured in plasma and serum samples taken within 24 hours of admission.
Potential Biases
The classification of infection status was made by one physician who was blinded to biochemical results, reducing work-up bias.
Limitations
The study had a risk of imperfect gold standard bias and included a heterogeneous patient population with varying severity of disease.
Participant Demographics
The patients were mostly elderly with a burden of comorbidity.
Statistical Information
P-Value
p<0.0001
Confidence Interval
95% confidence interval: 0.73–0.88
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website